{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:02:46Z","timestamp":1775710966973,"version":"3.50.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Cardiovascular Quality and Outcomes"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Global budget payments (GBP) are considered effective in containing health care expenditures; however, information on their impact on quality of cardiovascular care is limited. We aimed to evaluate the effects of GBP on utilization, outcomes, and costs for 3 major cardiovascular conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec sec-type=\"methods\">\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed claims data of hospital admissions in Maryland from fiscal year 2013 to 2018. Using segmented regression, we evaluated temporal trends in hospitalizations, length of stay, percutaneous coronary intervention and coronary artery bypass grafting volumes, case mix-adjusted 30-day readmission rates, risk-standardized mortality rates, and hospitalization charges in patients with principal diagnosis of heart failure, acute ischemic stroke, and acute myocardial infarction (AMI) in relation to GBP implementation. Trends in global cardiovascular procedure charges\/volumes were also studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec sec-type=\"results\">\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n              Hospitalization rates for congestive heart failure and AMI remained unaffected by GBP, while the gradient of ischemic stroke admissions decreased (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              &lt;0.0001). Length of stay slightly increased for patients with congestive heart failure (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              =0.03). Inpatient coronary artery bypass grafting surgeries decreased (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              &lt;0.0001). We observed a significant decrease in casemix-adjusted 30-day readmission rate in the AMI cohort beyond the prepolicy trend (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              =0.0069). There were no significant changes in mortality for any of the 3 conditions. Hospitalization charges increased for ischemic stroke (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              &lt;0.0001), remained constant for congestive heart failure (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              =0.1), and decreased for AMI (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              =0.0005). We observed a significant increase in electrocardiography rate charges (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              &lt;0.0001), coincidentally with a reduction in volumes (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              =0.0003).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Introducing GBP in Maryland had no perceivable adverse effects on inpatient outcomes and quality indicators for 3 major cardiovascular conditions. Savings were observed in the AMI cohort, possibly due to reduced unnecessary readmissions, efficiency improvements, or shifts to outpatient care. Reduced cardiovascular procedure volumes were counterbalanced by a proportional rise in charges. State-level adoption of GBP with pay-for-performance incentives may be effective for cost containment without adversely impacting quality of cardiovascular care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circoutcomes.120.007110","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T10:01:01Z","timestamp":1614160861000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Global Budget Payments on Cardiovascular Care in Maryland"],"prefix":"10.1161","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-8287","authenticated-orcid":true,"given":"Federico","family":"Viganego","sequence":"first","affiliation":[{"name":"Nazareth Cardiology, Philadelphia, PA (F.V.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7745-1972","authenticated-orcid":true,"given":"Eun K.","family":"Um","sequence":"additional","affiliation":[{"name":"AMSTAT Consulting, LLC, Bethesda, MD (A.E.K.U., J.R.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-2937","authenticated-orcid":true,"given":"Jasmine","family":"Ruffin","sequence":"additional","affiliation":[{"name":"AMSTAT Consulting, LLC, Bethesda, MD (A.E.K.U., J.R.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-8975","authenticated-orcid":true,"given":"Michael G.","family":"Fradley","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia (M.G.F.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Prida","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, University of South Florida Morsani College of Medicine, Tampa (X.P.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1256-9096","authenticated-orcid":true,"given":"Rocco","family":"Friebel","sequence":"additional","affiliation":[{"name":"Department of Health Policy, London School of Economics and Political Science, United Kingdom (R.F.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2012.0358"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1101416"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1404026"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1813621"},{"key":"e_1_3_5_6_2","unstructured":"Berenson RA Upadhyay DK Delbanco SF Murray R. Global Budgets for Hospitals. Research Report. The Urban Institute. https:\/\/www.urban.org\/sites\/default\/files\/05_global_budgets_for_hospitals.pdf. Accessed September 29 2019."},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3095"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czu119"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjdsi.2013.04.003"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198307213090306"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.2307\/3350305"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2009.03.008"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1508037"},{"key":"e_1_3_5_14_2","unstructured":"Haber SB Beil H Amico P Morrison M Akhmerova V Beadles C. Berzin O Cole-Beebe M Evron A Greenwald L et al. Evaluation of the Maryland All-Payer Model Third Annual Report. https:\/\/downloads.cms.gov\/files\/cmmi\/md-all-payer-thirdannrpt.pdf. Accessed December 30 2018."},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10754-018-9239-y"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.0385"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000659"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.5.1395"},{"key":"e_1_3_5_19_2","first-page":"35","article-title":"All-payer ratesetting: down but not out.","volume":"13","author":"Anderson GF","year":"1991","unstructured":"Anderson, GF. All-payer ratesetting: down but not out. Health Care Financ Rev. 1991;13:35\u201341.","journal-title":"Health Care Financ Rev"},{"key":"e_1_3_5_20_2","first-page":"e191","article-title":"Removing a constraint on hospital utilization: a natural experiment in Maryland.","volume":"20","author":"Kalman NS","year":"2014","unstructured":"Kalman, NS, Hammill, BG, Murray, RB, Schulman, KA. Removing a constraint on hospital utilization: a natural experiment in Maryland. Am J Manag Care. 2014;20:e191\u2013e199.","journal-title":"Am J Manag Care"},{"key":"e_1_3_5_21_2","unstructured":"Maryland Health Services Cost Review Commission Annual Reports. Maryland Governor\u2019s Report 2013. https:\/\/hscrc.state.md.us\/Documents\/pdr\/ar\/Governors-Report-2013-MD-HSCRC.pdf. Accessed December 22 2019."},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.611194"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.611186"},{"key":"e_1_3_5_24_2","unstructured":"Yale New Haven Health Services Corporation. Center for Outcomes Research & Evaluation (YNHHSC\/CORE). 2019 Condition-Specific Mortality Measures Updates and Specifications Report. Acute Myocardial Infarction \u2013 Version 13.0. Chronic Obstructive Pulmonary Disease \u2013 Version 8.0. Heart Failure \u2013 Version 13.0. Pneumonia \u2013 Version 13.0. Stroke \u2013 Version 8.0. https:\/\/www.cms.gov\/Medicare\/Quality-Initiatives-Patient-Assessment-Instruments\/HospitalQualityInits\/Measure-Methodology.html. Accessed June 25 2019."},{"key":"e_1_3_5_25_2","unstructured":"United States Census Bureau. State Population Tools and Components of Change: 2010-2018. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2010s-state-total.html. Accessed December 10 2019."},{"key":"e_1_3_5_26_2","unstructured":"United States Bureau of Labor Statistics. CPI inflation calculator. https:\/\/www.bls.gov\/data\/inflation_calculator.htm. Accessed December 10 2019."},{"key":"e_1_3_5_27_2","unstructured":"Maryland Health Services Cost Review Commission. Hospital rate orders and unit rates. https:\/\/hscrc.state.md.us\/Pages\/hsp_rates2.aspx. Accessed January 10 2020."},{"key":"e_1_3_5_28_2","unstructured":"Maryland Health Services Cost Review Commission. Accounting and Budget Manual. Section 200. https:\/\/hscrc.state.md.us\/Pages\/hdr_compliance.aspx. Accessed January 18 2020."},{"key":"e_1_3_5_29_2","unstructured":"Schuster A. Readmission Reductions Incentive Program (RRIP) for Rate Year (RY) 2021. Letter to Hospital CFOs. Maryland Health Services Cost Review Commission. 2018. https:\/\/hscrc.state.md.us\/Documents\/RY%202021%20RRIP%20Memo.pdf. Accessed September 15 2019."},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1214\/088342307000000096"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.2002.00430.x"},{"key":"e_1_3_5_33_2","unstructured":"Haber S Beil H. Another Look At The Evidence On Hospital Global Budgets In Maryland: Have They Reduced Expenditures And Use?. Health Aff (Blog). 2018. https:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20180508.819968\/full\/. Accessed November 19 2019."},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/0046958016669016"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2005.04.004"},{"key":"e_1_3_5_36_2","first-page":"280","volume-title":"The Elgar Companion to Health Economics","author":"Tor I","year":"2006","unstructured":"Tor, I, Hilde, L. Capitation and incentives in primary care. The Elgar Companion to Health Economics. 2nd ed. Edward Elgar Publishing, Cheltenham, UK; 2006:280\u2013288.","edition":"2"},{"key":"e_1_3_5_37_2","first-page":"174","article-title":"The nominal and real effects of hospital global budgets in France.","volume":"32","author":"Redmon DP","year":"1995","unstructured":"Redmon, DP, Yakoboski, PJ. The nominal and real effects of hospital global budgets in France. Inquiry. 1995;32:174\u2013183.","journal-title":"Inquiry"},{"key":"e_1_3_5_38_2","unstructured":"Grube M Kaufman K York R. Decline In Utilization Rates Signals A Change In The Inpatient Business Model. Health Aff (Blog). 2013. https:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20130308.029038\/full\/. Accessed November 19 2019."},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjdsi.2014.03.002"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.13162"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.0112"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.7455"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05366"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.13161"},{"key":"e_1_3_5_45_2","unstructured":"Centers for Medicare & Medicaid Services. Maryland Total Cost of Care Model. https:\/\/innovation.cms.gov\/initiatives\/md-tccm\/. Accessed September 15 2019"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0895"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.004782"},{"key":"e_1_3_5_48_2","unstructured":"American Hospital Association. Trendwatch Chartbook 2018: Table 4.2 (Chicago 2018). https:\/\/www.aha.org\/system\/files\/2018-05\/2018-chartbook-table-4-2.pdf. Accessed January 29 2020"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2750"}],"container-title":["Circulation: Cardiovascular Quality and Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCOUTCOMES.120.007110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:36:51Z","timestamp":1715571411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCOUTCOMES.120.007110"}},"subtitle":["An Interrupted Time Series Analysis"],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1161\/CIRCOUTCOMES.120.007110"],"URL":"https:\/\/doi.org\/10.1161\/circoutcomes.120.007110","relation":{},"ISSN":["1941-7713","1941-7705"],"issn-type":[{"value":"1941-7713","type":"print"},{"value":"1941-7705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"2020-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e007110"}}